Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnostics
SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced it has signed a […]
Major Journal Publishes Landmark Proteomics Study Demonstrating Development of an Unprecedented New Clinical Cardiovascular Risk Test
In one of the largest proteomic studies ever conducted and published April 6 in the […]
SomaLogic to Provide 210 Million Protein Measurements to EPIC Researchers to Better Understand and Predict Cancer Development
SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that the company will […]
SomaLogic Announces Appointment of Adam Taich as Chief Business Officer
SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that Adam Taich has […]
SomaLogic Announces Exclusive Partnership with Illumina to Develop Sequencing-based Proteomic Solutions
SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a worldwide strategic collaboration […]
SomaLogic Announces Strategic Collaboration with University Hospitals Cleveland Medical Center to Treat Diabetic Patients at High Risk of Cardiovascular Disease
SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a strategic collaboration with […]
SomaLogic Expands Leadership Team with New Positions to Drive Commercial Success
CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a leader in AI data-driven proteomics technology, […]
SomaLogic Announces Appointment of Shaun Blakeman as Chief Financial Officer
CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a leader in AI-data driven proteomics technology, […]
Ixaka and SomaLogic Enter Research Collaboration to Develop Bispecific Agents for Oncology
Ixaka Ltd and SomaLogic today announce a research collaboration to support the development of aptamer-based […]
- Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration Read more
- Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease Read more
- Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas Read more
- Quell Therapeutics Signs Agreement with AstraZeneca to Develop and Commercialize Engineered Treg Cell Therapies for Autoimmune Diseases Read more
- Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430 Read more